0,917  0,003  Skin irritative effect
0,839  0,005  Mutagenic
0,824  0,005  Carcinogenic
0,716  0,028  Antiinflammatory
0,673  0,007  Eye irritation, high
0,628  0,010  Spasmolytic
0,596  0,023  Embryotoxic
0,598  0,025  TNF expression inhibitor
0,575  0,027  GST A substrate
0,561  0,036  Transcription factor NF kappa B inhibitor
0,567  0,056  Apoptosis agonist
0,526  0,025  Respiratory analeptic
0,518  0,036  Antibacterial
0,482  0,009  Antiulcerative
0,475  0,014  Renal disease treatment
0,489  0,029  GABA C receptor rho-3 antagonist
0,471  0,025  AR expression inhibitor
0,467  0,026  Caspase 3 stimulant
0,484  0,044  15-Lipoxygenase inhibitor
0,447  0,009  Carcinogenic, group 3
0,463  0,036  Teratogen
0,484  0,067  Caspase 9 stimulant
0,447  0,034  Antihypercholesterolemic
0,435  0,031  Analeptic
0,400  0,006  Acute respiratory distress syndrome (ARDS) treatment
0,424  0,033  Lipoprotein disorders treatment
0,411  0,025  Antineoplastic (lymphoma)
0,417  0,035  Cardioprotectant
0,406  0,038  Antineoplastic (brain cancer)
0,412  0,047  Cholesterol antagonist
0,363  0,008  Gastrin inhibitor
0,375  0,028  Vasodilator
0,366  0,041  Chemoprotective
0,375  0,057  Immunostimulant
0,333  0,028  Abortion inducer
0,347  0,042  Antiprotozoal (Leishmania)
0,341  0,036  Chemopreventive
0,344  0,048  Antioxidant
0,338  0,042  Proliferative diseases treatment
0,305  0,017  Genotoxic
0,349  0,061  Antifungal
0,334  0,047  NOS2 expression inhibitor
0,325  0,042  Hypolipemic
0,285  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,375  0,099  Calcium channel L-type activator
0,308  0,034  UDP-glucuronosyltransferase substrate
0,296  0,021  Anesthetic
0,315  0,044  Angiogenesis stimulant
0,303  0,036  Antineoplastic enhancer
0,318  0,055  Antineoplastic (multiple myeloma)
0,302  0,040  Nitric oxide antagonist
0,310  0,050  Cytostatic
0,337  0,079  Vasodilator, peripheral
0,300  0,043  Antiparasitic
0,346  0,092  Atherosclerosis treatment
0,318  0,066  NOS3 expression inhibitor
0,341  0,096  CYP2C19 inhibitor
0,325  0,089  Antineoplastic (lung cancer)
0,274  0,038  Antihelmintic
0,337  0,102  Antineoplastic (breast cancer)
0,305  0,071  Antineoplastic (ovarian cancer)
0,259  0,029  Protein-tyrosine phosphatase inhibitor
0,250  0,020  UGT2B9 substrate
0,292  0,065  Antihypoxic
0,282  0,060  Sensitization
0,287  0,067  UGT2B4 substrate
0,245  0,028  Lipid peroxidase inhibitor
0,280  0,063  GST M1-1 substrate
0,235  0,020  Protein-tyrosine phosphatase 1B inhibitor
0,259  0,046  Sedative
0,248  0,040  Neurotrophic factor enhancer
0,249  0,042  UGT2B7 substrate
0,224  0,026  Anesthetic local
0,257  0,060  Cytotoxic
0,270  0,073  UGT1A9 substrate
0,222  0,028  Antidiabetic (type 1)
0,279  0,087  Antipsoriatic
0,270  0,080  Antituberculosic
0,199  0,011  TRPA1 agonist
0,273  0,085  Lipoxygenase inhibitor
0,211  0,024  Arachidonic acid antagonist
0,295  0,110  Ulceration
0,288  0,108  Antileukemic
0,240  0,061  Antihypertriglyceridemic
0,215  0,037  Protein kinase stimulant
0,244  0,075  Antineoplastic (liver cancer)
0,205  0,039  Melanin inhibitor
0,258  0,092  CYP1A2 substrate
0,189  0,024  Carcinogenic, group 2B
0,254  0,090  Radioprotector
0,269  0,109  FMO1 substrate
0,244  0,086  Antiprotozoal (Trypanosoma)
0,206  0,048  UGT1A3 substrate
0,263  0,106  Bone diseases treatment
0,195  0,038  Skin whitener
0,181  0,028  Antihemorrhagic
0,236  0,084  Superoxide dismutase inhibitor
0,217  0,066  Anesthetic general
0,209  0,060  Hepatoprotectant
0,176  0,030  GST P1-1 substrate
0,211  0,065  UGT1A1 substrate
0,190  0,045  UGT2B10 substrate
0,190  0,045  Interferon gamma antagonist
0,251  0,107  Antimycobacterial
0,182  0,041  GABA C receptor rho-2 antagonist
0,158  0,017  Electron transport complex I inhibitor
0,198  0,058  Lipocortins synthesis antagonist
0,265  0,130  Calcium channel activator
0,257  0,121  Apoptosis antagonist
0,256  0,121  Antithrombotic
0,268  0,136  Immunosuppressant
0,170  0,040  Monophenol monooxygenase inhibitor
0,192  0,066  Antipruritic, non-allergic
0,146  0,023  Carcinogenic, group 2A
0,173  0,052  Antineoplastic (squamous cell carcinoma)
0,152  0,032  Alcohol dehydrogenase substrate
0,142  0,023  Anabolic
0,142  0,026  Toll-Like receptor 4 antagonist
0,261  0,147  Histamine release inhibitor
0,225  0,111  Radiosensitizer
0,263  0,150  Antipruritic, allergic
0,126  0,014  GABA aminotransferase inhibitor
0,180  0,068  Succinate dehydrogenase inhibitor
0,141  0,030  Adenylate kinase inhibitor
0,153  0,045  Cyclooxygenase 3 inhibitor
0,142  0,036  Photosensitizer
0,158  0,052  Neurotrophic factor
0,133  0,027  Antiviral (Coronavirus)
0,133  0,027  Antiviral (SARS coronavirus)
0,218  0,112  Antiosteoporotic
0,209  0,104  Antineoplastic (renal cancer)
0,118  0,013  Glycine receptor agonist
0,147  0,043  Coagulant
0,159  0,057  Antiacne
0,200  0,098  Free radical scavenger
0,151  0,051  Farnesoid X receptor antagonist
0,142  0,042  Microtubule formation inhibitor
0,248  0,151  CYP2C9 substrate
0,163  0,065  Carcinogenic, group 1
0,132  0,036  Gastric antisecretory
0,143  0,048  Cholesterol synthesis inhibitor
0,120  0,025  Transcription factor NF kappa B stimulant
0,190  0,099  Age-related macular degeneration treatment
0,155  0,065  Antineoplastic (carcinoma)
0,125  0,036  GABA C receptor rho-1 antagonist
0,106  0,017  Elastase 1 inhibitor
0,131  0,042  GABA C receptor antagonist
0,191  0,102  UGT1A6 substrate
0,148  0,060  Antifungal enhancer
0,154  0,066  Hair growth stimulant
0,205  0,121  Antineoplastic (melanoma)
0,194  0,112  Cardiovascular analeptic
0,193  0,111  RNA-directed DNA polymerase inhibitor
0,089  0,007  Squalene synthetase inhibitor
0,107  0,026  Glycine receptor antagonist
0,105  0,025  Lipase inhibitor
0,218  0,138  FMO3 substrate
0,135  0,057  Vanilloid 1 agonist
0,156  0,078  Uterine stimulant
0,111  0,034  Phosphodiesterase 6D inhibitor
0,095  0,018  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,144  0,068  Antifungal (Cryptococcus)
0,127  0,051  Glutathione S-transferase substrate
0,121  0,045  Antiinfertility, female
0,161  0,086  Phospholipase C inhibitor
0,200  0,128  Antineoplastic (pancreatic cancer)
0,107  0,037  Ornithine decarboxylase inhibitor
0,143  0,075  Adenylate cyclase stimulant
0,199  0,133  CYP2C19 substrate
0,197  0,131  Antineoplastic (sarcoma)
0,180  0,116  Antineoplastic (lymphocytic leukemia)
0,216  0,152  Angiogenesis inhibitor
0,073  0,011  Kainate receptor antagonist
0,142  0,081  Antiviral (Influenza A)
0,133  0,073  Amylase inhibitor
0,138  0,080  Ca2+-transporting ATPase inhibitor
0,121  0,064  Antiviral (Influenza B)
0,096  0,039  Antiprotozoal activity enhancer
0,100  0,044  Arylamine N-Acetyltransferase substrate
0,144  0,091  UGT1A4 substrate
0,079  0,027  Neuraminidase inhibitor
0,054  0,004  Elastase 2B inhibitor
0,054  0,004  Elastase 3A inhibitor
0,054  0,004  Elastase 3B inhibitor
0,109  0,059  Mediator release inhibitor
0,182  0,133  Antihypotensive
0,103  0,054  UGT2B11 substrate
0,098  0,049  Antineoplastic alkaloid
0,116  0,071  DNA polymerase I inhibitor
0,154  0,110  Non-steroidal antiinflammatory agent
0,098  0,053  Antiviral (Rhinovirus)
0,092  0,048  Antispirochetal
0,159  0,117  CYP2B6 inhibitor
0,086  0,044  Ca(v)3.1 blocker
0,189  0,147  Flavin-containing monooxygenase substrate
0,074  0,032  Glutamate (mGluR6) antagonist
0,163  0,122  Antineoplastic (glioma)
0,159  0,118  Anticonvulsant
0,066  0,025  Elastase inhibitor
0,171  0,131  VCAM1 expression inhibitor
0,051  0,013  Kainate receptor agonist
0,072  0,033  Neuraminidase (influenza) inhibitor
0,215  0,177  Stroke treatment
0,087  0,053  Vanilloid agonist
0,102  0,069  UGT2B1 substrate
0,092  0,059  Thioredoxin inhibitor
0,146  0,116  LDLR expression enhancer
0,130  0,101  Phospholipase A2 inhibitor
0,110  0,082  Antiseptic
0,076  0,049  Glutamate dehydrogenase inhibitor
0,184  0,158  CYP2D6 substrate
0,184  0,161  Antineoplastic (bladder cancer)
0,181  0,159  Antiepileptic
0,064  0,043  Antiemphysemic
0,147  0,131  Antirickettsial
0,024  0,009  Neuraminidase (Influenza B) inhibitor
0,059  0,043  Androgen agonist
0,167  0,152  Peptidyltransferase inhibitor
0,064  0,050  Hypercalcemia treatment
0,050  0,036  CD45 antagonist
0,215  0,202  Antiprotozoal
0,061  0,049  CDC25B inhibitor
0,086  0,074  ABCA1 expression enhancer
0,064  0,052  Phosphofructokinase-1 inhibitor
0,039  0,028  Membrane dipeptidase inhibitor
0,048  0,037  Squalene epoxidase inhibitor
0,116  0,105  Antieczematic
0,176  0,165  Prostate cancer treatment
0,198  0,188  CYP3A4 substrate
0,041  0,032  Leukocyte elastase inhibitor
0,147  0,138  Insulin sensitizer
0,077  0,068  Inducible nitric-oxide synthase inhibitor
0,031  0,024  Methionyl aminopeptidase 1 inhibitor
0,181  0,174  Tyrosine 3 hydroxylase inhibitor
0,149  0,143  Antiglaucomic
0,053  0,048  Biliverdin reductase inhibitor
0,021  0,017  Vitamin D receptor antagonist
0,192  0,187  CTGF expression inhibitor
0,081  0,078  Actinic keratosis treatment
0,080  0,077  Triose-phosphate isomerase inhibitor
0,085  0,083  Interleukin 12 antagonist
0,066  0,065  CDC25A inhibitor
0,031  0,030  Retinoid X alpha receptor agonist

